OakChart

Certara Inc

CERTHealthcare·Health Information Services·USA·Small·NASD·Nov 11 • 8:30 AM ET

12.44+0.31 (2.60%)
2026-11-11 14:40 CET
Market cap
1,849.58 USD m
Revenue, TTM
398.74 USD m
Net income, TTM
-7.60 USD m
Free cash flow, TTM
78.20 USD m
EPS diluted, TTM
-0.05
P/E
-
Compare

Price

CERT against its 20, 50 and 200-day averages
2050200beatmiss
4.006.008.0010.0012.008.8M17.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CERTclose 12.4420-day 10.8950-day 9.57200-day 7.3512.44

1.3% under 12.61 on 6 Nov 2026. Last 15 sessions, 27.9% high to low

Profile

CERT
52-week range, 98% of the way up
4.4512.61

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.

IndexRUT
Employees1576
IPODec 11, 2020
Beta1.24
ATR, 14d0.56
Rel volume0.01
Short float26.28%
Insider own36.33%
Inst own77.03%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.90B
Enterprise Value1.98B
Income-7.60M
Sales398.74M
Book/sh6.41
Cash/sh1.41
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1576
IPODec 11, 2020

Ratios

P/E-
Forward P/E31.45
PEG25.16
P/S4.76
P/B1.94
P/C8.83
P/FCF24.27
EV/EBITDA22.41
EV/Sales4.98
Quick Ratio2.58
Current Ratio2.58
Debt/Eq0.31
LT Debt/Eq0.30
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.05
EPS next Y0.40
EPS next Q0.10
EPS this Y-24.04%
EPS next Y18.36%
EPS next 5Y1.25%
EPS past 3/5Y- 50.19%
Sales past 3/5Y7.66% 11.45%
EPS Y/Y TTM-169.67%
Sales Y/Y TTM-4.05%
EPS Q/Q-317.89%
Sales Q/Q-9.29%
EarningsNov 05 BMO
EPS/Sales Surpr.3.93% 3.14%

Ownership

Insider Own36.33%
Insider Trans0.00%
Inst Own77.03%
Inst Trans-1.24%
ROA-1.65%
ROE-2.38%
ROIC-0.60%
Gross Margin49.87%
Oper. Margin4.44%
Profit Margin-1.91%
SMA2014.23%
SMA5029.97%
SMA20069.35%
Trades-

Technical

Shs Outstand152.54M
Shs Float97.13M
Short Float26.28%
Short Ratio9.61
Short Interest25.53M
52W High12.61 -1.35%
52W Low4.45 179.55%
Volatility6.70% 5.72%
ATR (14)0.56
RSI (14)72.80
Beta1.24
Rel Volume0.01
Avg Volume2.66M
Volume829

Performance

Perf Week12.17%
Perf Month29.58%
Perf Quarter52.64%
Perf Half Y159.71%
Perf YTD41.20%
Perf Year44.99%
Perf 3Y-7.85%
Perf 5Y-68.41%
Perf 10Y-
Recom2.38
Target Price12.68
Prev Close12.12
Price12.44
Change %2.60%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Mar 06, 2026DowngradeBBarclaysOverweight → Equal Weight$8-35.7%
Feb 27, 2026DowngradeCCraig HallumBuy → Hold$10-19.6%
Jan 06, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$13+4.5%
Nov 21, 2025InitiatedRRothschild & Co RedburnBuy$10-19.6%
Nov 13, 2025InitiatedBBMO Capital MarketsMarket Perform$9-27.7%
Sep 29, 2025InitiatedCCraig HallumBuy$16+28.6%
Jul 03, 2025ResumedMMorgan StanleyEqual-Weight$16+28.6%
May 08, 2025UpgradeBBarclaysEqual Weight → Overweight$14+12.5%
Feb 27, 2025InitiatedTTD CowenBuy$16+28.6%
Sep 27, 2024UpgradeUUBSNeutral → Buy$16+28.6%

Peers

Mkt cap
TickerCompanyMkt cap
SDGRSchrodinger Inc2.51B
VEEVVeeva Systems Inc49.94B
TEMTempus AI Inc15.11B
RXRXRecursion Pharmaceuticals Inc2.32B
ICLRIcon Plc15.51B
ABSIAbsci Corp1.79B
IQVIQVIA Holdings Inc45.34B
CRLCharles River Laboratories International Inc16.57B
MEDPMedpace Holdings Inc18.23B
DNAGinkgo Bioworks Holdings Inc824.24M

Insider trading

latest 14 of 18
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Pedersen Leif EOfficerSep 03 '26Proposed Sale8.3236,066300,069Sep 03 11:09 AM
Anhalt RonaChief Human Resources OfficerJun 01 '26Option Exercise0.007,147019,030Jun 02 05:15 PM
Corcoran DanielSVP and General CounselJun 01 '26Option Exercise0.0022,830039,939Jun 02 05:14 PM
Collins CynthiaDirectorMay 14 '26Option Exercise0.0015,757051,846May 15 04:31 PM
Reynders John V WChief Financial OfficerMay 14 '26Option Exercise0.0015,757026,466May 15 04:29 PM
BROSHY ERANChairmanMay 14 '26Option Exercise0.0015,757050,708May 15 04:28 PM
Bedi ArjunDirectorMay 14 '26Option Exercise0.005,54705,547May 15 04:28 PM
CASHMAN JAMES E IIIChairmanMay 14 '26Option Exercise0.0015,7570484,197May 15 04:27 PM
Killefer NancyDirectorMay 14 '26Option Exercise0.0015,757051,846May 15 04:26 PM
Crane Rosemary ADirectorMay 14 '26Option Exercise0.0015,757045,672May 15 04:26 PM
WALSH MATTHEW MDirectorMay 14 '26Option Exercise0.0015,7570213,316May 15 04:25 PM
Resnick Jon MatthewChief Executive OfficerMay 11 '26Option Exercise0.0059,766059,766May 13 04:53 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '26Option Exercise0.0033,1670113,744Apr 03 04:11 PM
McKemey AdrianPresident, Drug Dev. SolutionsApr 01 '26Option Exercise0.0010,849010,849Apr 03 04:10 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.63B
IWMiShares Russell 2000 Index FundAUM: 78.30B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.54B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.50B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.82B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.11B
VXFVanguard Extended Market Index ETFAUM: 30.61B

News

latest 14 of 206
  • Certara's Software Reacceleration Carries A Beat, But Services Drag And A Trimmed EPS Ceiling Test A Stock Up 75% (Earnings Whispers) +9.83%
  • Certara Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • Certara's 73% Rally Meets Its Real Test: Can Services Finally Turn As Software Rebounds? (Earnings Whispers)
  • Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026 (GlobeNewswire)
  • What Could Go Wrong With Recursion Pharmaceuticals Stock? (Trefis) +5.67%
  • Loading…
  • Certara Reports Second Quarter 2026 Financial Results (GlobeNewswire)
  • An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers (PR Newswire)
  • Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 (GlobeNewswire) +5.85%
  • Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT) (InvestorsHub)
  • Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit (GlobeNewswire)
  • As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
  • The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
  • Certara Announces CFO Transition (GlobeNewswire) -8.13%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0900.0870.04094.9092.0111
2026Q22026-08-040.0800.0890.06693.2798.0910
2026Q12026-05-110.0900.106-0.056106.92106.1311
2025Q42026-02-260.0900.112-0.037103.6103.0710
2025Q32025-11-060.1400.1140.010104.62104.5211
2025Q22025-08-060.0700.100-0.012104.57104.0510
2025Q12025-05-050.1400.1130.029106105.0910
2024Q42025-02-260.1500.1230.041100.3698.899
2024Q32024-11-060.1300.108-0.00994.8295.5110
2024Q22024-08-060.0700.103-0.07893.3196.019
2024Q12024-05-070.1000.103-0.02996.6593.6410
2023Q42024-02-290.0900.110-0.07888.0086.689
2023Q32023-11-080.1100.109-0.30885.5886.256
2023Q22023-08-090.1200.1250.02990.4592.187
2023Q12023-05-080.1200.1220.00990.3090.997
2022Q42023-03-010.1600.1300.05886.6382.556

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.1680.140-0.323243.51240.58
2021FY0.1700.288-0.089286.1293.39
2022FY0.4600.4390.092335.64331.52
2023FY0.4300.451-0.348354.3352.99
2024FY0.4500.428-0.075385.15383.77
2025FY0.4400.459-0.010418.8418.05
2026FY-0.334--380.8
2027FY-0.396--394.37
2028FY-0.457--421.23
2029FY-0.515--439.92

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10104295.5390.80100.6
2026Q4S2026-11-05104295.4490.80100.6
2026Q4S2026-10-27101194.7789.5697.80
2026Q4S2026-10-25101294.7789.5697.80
2026Q4S2026-10-18101394.7789.5697.80
2026Q4S2026-10-16101794.7789.5697.80
2026Q4S2026-10-14101794.9089.5697.80
2026Q4S2026-10-07100894.7289.5697.80
2026Q4S2026-09-28100894.6989.5697.80
2026Q4S2026-08-1390894.5489.5697.80
2026Q4S2026-08-1190795.0189.5699.60
2026Q4S2026-08-0480695.1489.5699.60
2026Q4S2026-07-2691097.5194.8999.80
2026Q4S2026-07-2591197.5194.8999.80

Estimate history

EPS, annual-0.211-0.057-0.323-0.0890.092-0.348-0.075-0.01-0.0471
Period20182019202020212022202320242025TTM
EPS, quarterly-0.0090.0410.029-0.0120.01-0.037-0.0560.066-0.021
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual163.719208.511243.53286.104335.644354.337385.148418.838398.74
Period20182019202020212022202320242025TTM
Sales, quarterly94.82100.361106.004104.57104.616103.648106.91593.27194.901
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual157.338157.338152.979159.659159.526159.848161.009159.14152.543
Period20182019202020212022202320242025MRQ
Shares, quarterly160.9161.009161.476160.615159.397159.14153.325152.499152.543
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue398.74418.84385.15354.34335.64286.10243.53208.51163.72
Cost of Goods Sold Incl. D&A199.87217.68208.11186.55175.74152.47140.62118.61105.08
Gross Profit198.87201.16177.04167.79159.91133.64102.9189.9058.63
Selling, General and Administrative Excl. Other181.17175.39158.22153.74124.02106.03127.3370.2963.29
Research and Development44.0441.0437.1034.1728.2020.3819.6411.6310.48
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income17.7025.7718.8214.0535.8927.61-24.4219.61-4.65
Interest Expense20.0919.7421.5222.9217.7716.8425.3028.0027.80
Unusual Expense19.044.7520.5554.834.3314.960.000.000.00
Net Income Before Taxes-18.427.62-17.18-55.1418.75-3.38-50.18-9.15-32.56
Income Taxes5.909.21-5.130.214.029.89-0.78-0.230.70
Consolidated Net Income-24.32-1.59-12.05-55.3614.73-13.27-49.40-8.93-33.26
Net Income From Continuing Operations-24.32-1.59-12.05-55.3614.73-13.27-49.40-8.93-33.26
Net Income-7.60-1.59-12.05-55.3614.73-13.27-49.40-8.93-33.26
EPS (Recurring)0.040.010.01-0.110.11-0.02-0.32-0.06-0.21
EPS (Basic, Before Extraordinaries)-0.05-0.01-0.08-0.350.09-0.09-0.32-0.06-0.21
EPS (Diluted)-0.05-0.01-0.08-0.350.09-0.09-0.32-0.06-0.21
EBITDA88.54100.9386.8570.1388.3672.7218.3361.1732.36
Non-Operating Income (Expense)3.006.346.078.554.970.81-0.47-0.76-0.11
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense21.8226.1329.7224.5028.4121.5247.091.231.35
Price To Sales Ratio3.523.374.447.897.6314.8821.18--
Gross Margin49.8748.0345.9747.3547.6446.7142.2643.1235.81
Operating Margin4.446.154.893.9710.699.65-10.039.41-2.84
Net Margin-1.91-0.38-3.13-15.624.39-4.64-20.28-4.28-20.31
Shares Outstanding152.54159.14161.01159.85159.53159.66152.98157.34157.34
Market Capitalization1,849.581,849.581,714.522,811.672,565.954,538.084,672.044,843.85-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue94.9093.27106.92103.65104.62104.57106.00100.36
Cost of Goods Sold Incl. D&A43.2046.8556.2053.6253.7054.8755.4952.25
Gross Profit51.7146.4250.7250.0250.9249.7050.5248.11
Selling, General and Administrative Excl. Other46.0843.5746.7744.7644.0844.5142.0540.56
Research and Development10.779.7112.2911.2810.278.9710.527.77
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5.632.853.955.276.845.198.477.55
Interest Expense5.044.994.945.125.014.804.815.00
Unusual Expense3.303.058.254.433.83-4.360.851.55
Net Income Before Taxes-1.18-6.39-7.94-2.91-0.276.254.542.18
Income Taxes2.40-0.310.822.98-1.798.22-0.20-4.40
Consolidated Net Income-3.58-6.08-8.76-5.891.52-1.974.746.58
Net Income From Continuing Operations-3.58-6.08-8.76-5.891.52-1.974.746.58
Net Income-3.1610.21-8.76-5.891.52-1.974.746.58
EPS (Recurring)-0.010.08-0.02-0.020.03-0.030.030.05
EPS (Basic, Before Extraordinaries)-0.020.07-0.06-0.040.01-0.010.030.04
EPS (Diluted)-0.020.07-0.06-0.040.01-0.010.030.04
EBITDA21.9419.1823.0424.3725.4624.0127.0925.77
Non-Operating Income (Expense)1.53-1.211.301.371.741.501.731.18
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.754.815.786.477.566.515.598.36
Price To Earnings Ratio---130.71247.37---
Price To Sales Ratio3.522.482.143.354.724.644.054.46
Gross Margin54.4849.7747.4348.2648.6747.5347.6547.94
Operating Margin5.933.063.695.086.534.977.997.53
Net Margin-3.3310.95-8.20-5.691.46-1.884.476.55
Shares Outstanding152.54152.50153.33159.14159.40160.61161.48161.01
Market Capitalization1,849.581,018.95907.101,403.201,962.831,898.141,594.081,714.52

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments189.39179.18234.95239.69186.62273.2929.7612.19
Short Term Receivables116.27119.0893.2688.8178.3164.8052.3649.88
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets9.4612.5911.9913.769.808.495.416.86
Total Current Assets315.12310.85340.20342.25274.73346.5887.5268.93
Net Property, Plant & Equipment13.7916.0112.2716.8315.573.874.625.40
Total Investments and Advances0.000.001.153.740.000.000.001.16
Intangible Assets1,220.791,242.251,203.381,204.531,215.19915.04942.99973.90
Deferred Tax Assets5.243.964.243.704.072.740.830.84
Other Assets1.642.031.901.882.171.161.101.26
Total Assets1,556.581,575.101,563.141,572.921,511.731,269.401,037.071,051.49
Short Term Debt Incl. Current Port. of LT Debt6.888.313.028.018.354.964.263.44
Accounts Payable3.433.505.177.537.466.394.924.91
Income Tax Payable1.430.431.012.221.400.850.000.17
Other Current Liabilities141.65133.85120.8285.3975.0263.1453.8356.94
Total Current Liabilities153.38146.09130.02103.1692.2275.3463.0065.45
Long Term Debt298.57303.59295.17300.12300.03294.42397.12404.84
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities34.3740.4250.8365.0576.1075.8982.1685.67
Other Liabilities7.4726.3540.2824.941.531.612.742.76
Total Liabilities493.79516.45516.30493.26469.88447.27545.02558.72
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,062.801,058.661,046.841,079.661,041.85822.13492.05492.77
Total Shareholders Equity1,062.801,058.661,046.841,079.661,041.85822.13492.05492.77
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity1,062.801,058.661,046.841,079.661,041.85822.13492.05492.77
Total Liabilities & Stockholders Equity1,556.581,575.101,563.141,572.921,511.731,269.401,037.071,051.49
Book Value Per Share6.686.586.556.776.535.373.133.13
Tangible Book Value Per Share-0.99-1.14-0.98-0.78-1.09-0.61-2.87-3.06
Full-Time Employees1,5761,5461,3911,2041,114300841-
Price to Book Ratio1.891.632.672.444.366.2711.18-
Return on Assets-0.10-0.77-3.530.96-0.95-4.28-0.85-
Return on Equity-0.15-1.14-5.211.39-1.42-7.52-1.81-
Return on Invested Capital-0.12-0.88-4.121.07-0.99-4.42-1.00-3.71
Quick Ratio2.052.132.623.322.984.601.391.05
Current Ratio2.052.132.623.322.984.601.391.05

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-27.38-1.59-12.05-55.3614.73-13.27-49.40-8.93-33.26
Depreciation67.7675.1668.0356.0752.4745.1242.7541.5637.01
Other Funds (Non Cash)41.6731.1945.36103.2833.1332.6465.993.353.07
Funds from Operations65.4696.4488.6587.4788.8263.3051.5229.283.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital15.77-0.12-8.18-4.723.73-2.92-6.718.748.32
Cash from Operating Activities81.2396.3380.4782.7592.5460.3944.8138.0211.59
Capital Expenditures-29.75-26.56-21.04-15.32-12.53-8.90-7.94-9.52-11.48
Net Assets From Acquisitions0.000.00-91.33-64.23-15.31-261.02-0.680.00-62.42
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources78.240.000.000.000.000.000.000.000.00
Cash from Investing Activities48.49-26.56-112.37-79.55-27.84-269.92-8.61-9.52-73.91
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-61.33-42.610.000.000.00133.35316.300.000.00
Repurchase of Common Pref Stock-61.33-42.610.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.00133.35316.300.000.00
Proceedsfrom Stock Options0.000.000.000.000.00133.35316.300.000.00
Issuance or Reduction of Debt, Net-2.96-2.992.83-3.04-3.31-6.83-104.36-8.4464.96
Change in Long Term Debt-2.96-2.992.83-3.04-3.31-6.83-104.36-8.4464.96
Issuance of Long Term Debt0.000.005.090.000.00-2.8519.880.0073.94
Reduction of Long Term Debt-2.96-2.99-2.25-3.04-3.31-3.97-124.24-8.44-8.98
Net Financing Active Other Cash Flow-23.78-18.39-23.84-6.40-4.05-3.13-3.73-0.05-7.66
Other Financing Activities Uses-23.78-18.39-23.84-6.40-4.05-3.13-3.98-0.70-8.77
Cash from Financing Activities-88.06-63.99-21.01-9.45-7.36123.39208.21-8.4957.30
Exchange Rate Effect0.574.43-2.861.50-4.28-0.52-0.88-2.44-1.34
Net Change in Cash42.2210.21-55.77-4.7453.06-86.67243.5317.57-6.35
Free Cash Flow78.2094.5678.8480.9891.1159.2443.9535.926.83
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow17.9614.9421.6734.5228.1171.88117.38--
Deferred Taxes & Investment Tax Credit--8.32-12.70-16.52-11.51-1.18-7.83-6.70-3.55

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments214.93184.14149.48189.39172.71162.27
Short Term Receivables106.31113.90107.61116.2798.47106.33
Inventories0.000.000.000.000.000.00
Other Current Assets14.1114.1513.479.4612.1212.80
Total Current Assets335.35312.19270.56315.12283.30281.39
Net Property, Plant & Equipment10.4610.6213.0713.7914.2214.66
Total Investments and Advances4.871.150.000.000.000.00
Intangible Assets1,051.661,063.331,204.021,220.791,232.581,241.60
Deferred Tax Assets11.1211.1211.125.243.963.96
Other Assets1.471.391.601.641.801.83
Total Assets1,414.921,399.801,500.371,556.581,535.861,543.45
Short Term Debt Incl. Current Port. of LT Debt5.936.126.676.887.177.32
Accounts Payable4.322.723.693.433.465.48
Income Tax Payable8.776.484.261.432.521.70
Other Current Liabilities111.15107.07129.50141.65122.37115.93
Total Current Liabilities130.17122.40144.12153.38135.52130.44
Long Term Debt295.26295.82297.29298.57299.51300.54
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities4.918.9534.7534.3730.8536.56
Other Liabilities6.676.127.167.475.175.33
Total Liabilities437.01433.28483.32493.79471.05472.87
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity977.91966.511,017.041,062.801,064.811,070.58
Total Shareholders Equity977.91966.511,017.041,062.801,064.811,070.58
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity977.91966.511,017.041,062.801,064.811,070.58
Total Liabilities & Stockholders Equity1,414.921,399.801,500.371,556.581,535.861,543.45
Book Value Per Share6.416.346.636.686.686.67
Tangible Book Value Per Share-0.48-0.63-1.22-0.99-1.05-1.06
Full-Time Employees---1,576--
Price to Book Ratio1.890.990.851.321.831.74
Return on Assets-1.65-1.31-0.99-0.100.710.52
Return on Equity-2.38-1.89-1.44-0.151.030.76
Return on Invested Capital-0.250.81-0.67-0.430.11-0.14
Quick Ratio2.582.551.882.052.092.16
Current Ratio2.582.551.882.052.092.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-3.58-9.14-8.76-5.891.52-1.97
Depreciation16.3213.2519.0919.1018.6318.82
Other Funds (Non Cash)6.2312.0814.968.4012.692.75
Funds from Operations11.9413.3919.3920.7427.367.13
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital18.74-3.35-7.698.084.9610.72
Cash from Operating Activities30.6810.0411.6928.8232.3117.84
Capital Expenditures-8.24-7.69-6.78-7.03-6.79-6.96
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources8.8069.440.000.000.000.00
Cash from Investing Activities0.5661.74-6.78-7.03-6.79-6.96
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.00-17.39-40.00-3.94-13.67-25.00
Repurchase of Common Pref Stock0.00-17.39-40.00-3.94-13.67-25.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.74-0.74-0.74-0.74-0.75-0.75
Change in Long Term Debt-0.74-0.74-0.74-0.74-0.75-0.75
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.74-0.74-0.74-0.74-0.75-0.75
Net Financing Active Other Cash Flow-0.18-20.46-3.00-0.14-0.06-4.94
Other Financing Activities Uses-0.18-20.46-3.00-0.14-0.06-4.94
Cash from Financing Activities-0.92-38.59-43.74-4.81-14.48-30.69
Exchange Rate Effect0.481.46-1.08-0.29-0.592.99
Net Change in Cash30.7934.65-39.9116.6810.45-16.82
Free Cash Flow29.919.4211.0627.8132.0917.91
Price to Free Cash Flow17.9612.5810.1214.8416.9618.75

Revenue breakdown

Services-Prepackaged Software2024: 385.15M 2025: 418.84M
Americas2024: 281.49M 2025: 291.60M
Asia Pacific2024: 27.09M 2025: 34.61M
EMEA2024: 76.57M 2025: 92.63M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3026.28%25.5M97.1M2.81M
2026-10-1526.44%25.7M97.1M3.06M
2026-09-3028.53%27.7M97.1M3.18M
2026-09-1529.67%28.8M97.1M3.62M
2026-08-3129.83%29.0M97.1M3.95M
2026-08-1425.69%25.2M98.2M4.24M
2026-07-3127.42%28.8M105.2M4.21M
2026-07-1527.72%29.7M107.3M4.05M
2026-06-3027.35%29.4M107.4M4.19M
2026-06-1526.56%28.5M107.4M3.96M
2026-05-2926.94%28.8M106.7M3.92M
2026-05-1523.69%25.3M106.7M3.83M
2026-04-3022.54%24.1M107.0M3.75M
2026-04-1521.02%22.5M107.0M3.59M
2026-03-3120.04%22.3M111.3M3.27M
2026-03-1321.38%23.8M111.3M2.77M
2026-02-2720.19%22.5M111.3M2.41M
2026-02-1319.67%21.9M111.4M2.29M
2026-01-3018.69%20.8M111.4M2.26M
2026-01-1519.36%21.6M111.4M2.21M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.507.0011.906.700.0001.000.000.968-0.0580.001
call5.004.509.406.6010.8981090.000.931-0.0690.003
call7.502.805.304.733.6663431.000.852-0.0980.005
call10.001.154.202.304.2641870.000.734-0.1390.007
call12.500.200.500.450.8295,0836.000.504-0.0630.008
call15.000.000.450.101.65147.004.000.259-0.0540.006
put2.500.000.350.007.6640.000.00-0.031-0.0520.001
put5.000.000.450.054.8635.000.00-0.068-0.0620.003
put7.500.001.950.104.17613.000.00-0.148-0.0970.005
put10.000.004.000.304.15822.000.00-0.266-0.1380.007
put12.500.002.501.602.8976.000.00-0.496-0.0620.008
put15.000.655.500.004.5150.000.00-0.741-0.0530.006

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-09-03144Filing for proposed sale of securities under Rule 144.SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-078-KCurrent report2026-08-04SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-048-KCurrent report2026-07-30SEC
2026-07-173Initial statement of beneficial ownership of securities2026-07-15SEC
2026-07-14SCHEDULE 13G/ASEC
2026-07-08SCHEDULE 13G/ASEC
2026-06-178-KCurrent report2026-06-11SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-154Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-158-KCurrent report2026-05-14SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-11200.00K100

Institutional holders

Manager% owned
BlackRock, Inc.12.10%
DEERFIELD MANAGEMENT COMPANY, L.P.4.83%
Haveli Investment Management LLC4.76%
Jefferies Financial Group Inc.4.65%
VANGUARD PORTFOLIO MANAGEMENT LLC4.54%
DIMENSIONAL FUND ADVISORS LP4.25%
WASATCH ADVISORS LP3.62%
VANGUARD CAPITAL MANAGEMENT LLC3.40%
STATE STREET CORP3.10%
GEODE CAPITAL MANAGEMENT, LLC2.09%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF4.52%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.39%
iShares Russell 2000 ETF1.94%
VANGUARD SMALL-CAP INDEX FUND1.72%
Touchstone Strategic Trust-Touchstone Small Company Fund1.41%
Wasatch Small Cap Value Fund1.37%
First Trust Health Care AlphaDEX Fund1.30%
U.S. SMALL CAP VALUE PORTFOLIO1.11%
VANGUARD SMALL-CAP VALUE INDEX FUND1.09%
VANGUARD EXPLORER FUND0.92%

OakChart. CERT. Cached 15 minutes.